Overview

Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in EDs in Pakistan

Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
0
Participant gender:
All
Summary
The primary objective is to determine if the administration of a single dose of oral ondansetron (an anti-vomiting medication), compared to placebo, results in a reduction in intravenous (IV) rehydration therapy in children presenting for emergency department care with some dehydration, vomiting and diarrhea in Pakistan. SOME Dehydration is defined as 2 or more of the following signs and symptoms: - Restlessness, irritability - Sunken Eyes - Drinks eagerly, thirsty - Skin pinch goes back slowly
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Dr. Stephen Freedman
Sarah Williamson-Urquhart
Collaborators:
Aga Khan University
Bill and Melinda Gates Foundation
Thrasher Research Fund
Treatments:
Ondansetron
Criteria
Inclusion Criteria:

- Age 6 - 59 months (0.5 - 5 years)

- Symptoms consistent with gastroenteritis (must have a & b)

1. 1 episode of nonbilious, nonbloody vomiting within the 4 hours preceding triage
The requirement for only 1 vomiting episode is based on prior work which
similarly required 1 vomiting episode within 4 hours of triage. The later study
reported a 17% absolute reduction in the use of IV rehydration. The vast majority
of children seeking care and enrolled in the aforementioned study had a
significantly greater number of vomiting episodes in the preceding 24 hour (mean
>9 episodes).29

2. Presence of ≥ 1 episode of diarrhea during the illness We require the presence of
only 1 diarrheal stool to enhance our probability of enrolling children with
enteritis (as opposed to other diagnoses).

In fact, of the 8 RCTs performed using antiemetics in children with gastroenteritis in
developed countries, only 1 even required the presence of any diarrhea as part of the
eligibility criteria (and that study required a single diarrheal stool).

- Presence of "SOME" dehydration - 2 or more of the following signs: i. Restlessness,
irritability; ii. Sunken Eyes; iii.Drinks eagerly, thirsty; iv.Skin pinch goes back slowly

Exclusion Criteria:

- Weight <8 kg

- Vomiting or diarrhea for > 7 days

- Malnutrition: The WHO definition will be employed - weight for height below -3z scores
of the median WHO growth standards

- Severe dehydration (WHO criteria) or hypotension defined as a systolic blood pressure
<70 mm Hg in infants 1 month to 12 months, < 70 mm Hg + (2 x age in years) in children
1-10 years, < 90 mm Hg in children ≥ 10 years

- Prior abdominal surgery (excluding hernia)

- Bilious or bloody vomitus

- Known hypersensitivity to ondansetron or any serotonin receptor antagonist

- History or family history of prolonged QT syndrome

- Taking apomorphine or any medication that is generally accepted as having a risk of
causing torsades de pointes

- Patients previously enrolled in the study

- Follow-up will not be possible